MODEL RELEASED. Young woman blowing nose on tissue. How rapid is the onset of effective action when using azelastine HCl 0.15% to relieve nasal symptoms of seasonal allergic rhinitis? Azelastine HCl 0 ...
Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...
The trial, led by Professor Robert Bals, Director of the Department of Internal Medicine V at Saarland University Medical Center and Professor of Internal Medicine at Saarland University, divided the ...
Researchers say people using a common allergy nasal spray, azelastine, were 69% less likely to contract COVID-19. Participants in the trial were also 71% less likely to catch the common cold than ...
A familiar allergy spray may do more than ease sneezing, researchers find azelastine could help block COVID-19 and other respiratory viruses, pointing to an accessible new line of defense. Study: ...
“Azelastine nasal spray could provide an additional easily accessible prophylactic to complement existing protective measures, especially for vulnerable groups, during periods of high infection rates, ...
FRIDAY, Sept. 5, 2025 (HealthDay News) -- Azelastine nasal spray is associated with a reduced risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, according to a study ...
The trial, led by Professor Robert Bals, Director of the Department of Internal Medicine V at Saarland University Medical Center and Professor of Internal Medicine at Saarland University, divided the ...
New research suggests an over-the-counter nasal spray containing Azelastine may help lower the risk of getting COVID-19. Azelastine may offer some protection against other viruses, too. Doctors ...
A new study has discovered another way to potentially prevent COVID-19. Researchers at Saarland University in Germany headed a clinical trial that found a nasal spray could reduce the risk of ...
Girl blowing nose, allergic rhinitis, nasal congestion The primary endpoint was time from baseline to azelastine’s onset of the usefulness, which researchers assessed by comparing azelastine and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback